Peter F. Bodary

1.7k total citations
44 papers, 1.3k citations indexed

About

Peter F. Bodary is a scholar working on Epidemiology, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Peter F. Bodary has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 18 papers in Physiology and 11 papers in Endocrine and Autonomic Systems. Recurrent topics in Peter F. Bodary's work include Adipokines, Inflammation, and Metabolic Diseases (14 papers), Regulation of Appetite and Obesity (11 papers) and Adipose Tissue and Metabolism (8 papers). Peter F. Bodary is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (14 papers), Regulation of Appetite and Obesity (11 papers) and Adipose Tissue and Metabolism (8 papers). Peter F. Bodary collaborates with scholars based in United States, Australia and India. Peter F. Bodary's co-authors include Daniel T. Eitzman, Yuechun Shen, Shufang Gu, James A. Shayman, Randal J. Westrick, Alyssa H. Hasty, George Broze, Robert L. Bard, Sanjay Rajagopalan and Robert D. Brook and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Peter F. Bodary

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter F. Bodary United States 20 454 451 287 233 218 44 1.3k
Concetta Di Febbo Italy 18 176 0.4× 221 0.5× 255 0.9× 59 0.3× 155 0.7× 31 1.0k
Michael J. Kraakman Australia 17 419 0.9× 546 1.2× 147 0.5× 88 0.4× 75 0.3× 29 1.5k
Kazuyuki Hida Japan 20 487 1.1× 700 1.6× 336 1.2× 178 0.8× 40 0.2× 37 1.8k
Hiroyuki Mori United States 15 610 1.3× 407 0.9× 125 0.4× 61 0.3× 83 0.4× 23 1.6k
Josef Wanninger Germany 22 482 1.1× 1.1k 2.5× 278 1.0× 181 0.8× 38 0.2× 36 1.8k
Atsuko Nakatsuka Japan 20 574 1.3× 757 1.7× 247 0.9× 183 0.8× 46 0.2× 50 2.2k
Hirotaka Isobe Japan 15 226 0.5× 192 0.4× 169 0.6× 39 0.2× 342 1.6× 29 1.2k
Nuria Matesanz Spain 18 246 0.5× 222 0.5× 115 0.4× 30 0.1× 128 0.6× 26 943
Jack C.‐R. Tsai Taiwan 9 392 0.9× 701 1.6× 299 1.0× 220 0.9× 20 0.1× 12 1.2k
Alexander Breitenstein Switzerland 21 251 0.6× 242 0.5× 565 2.0× 49 0.2× 89 0.4× 116 1.6k

Countries citing papers authored by Peter F. Bodary

Since Specialization
Citations

This map shows the geographic impact of Peter F. Bodary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter F. Bodary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter F. Bodary more than expected).

Fields of papers citing papers by Peter F. Bodary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter F. Bodary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter F. Bodary. The network helps show where Peter F. Bodary may publish in the future.

Co-authorship network of co-authors of Peter F. Bodary

This figure shows the co-authorship network connecting the top 25 collaborators of Peter F. Bodary. A scholar is included among the top collaborators of Peter F. Bodary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter F. Bodary. Peter F. Bodary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gross, M. Melissa, et al.. (2022). Designing for Cross-Cutting Skill Development and Diversity, Equity, and Inclusion in a Foundational Kinesiology Course. Kinesiology Review. 11(4). 343–352. 2 indexed citations
2.
3.
Desch, Karl C., et al.. (2018). α-galactosidase A deficiency promotes von Willebrand factor secretion in models of Fabry disease. Kidney International. 95(1). 149–159. 18 indexed citations
4.
Ma, Xiaoya, et al.. (2017). Iron elevation and adipose tissue remodeling in the epididymal depot of a mouse model of polygenic obesity. PLoS ONE. 12(6). e0179889–e0179889. 31 indexed citations
5.
Wang, Huili, et al.. (2013). α(1,3)-Fucosyltransferases FUT4 and FUT7 Control Murine Susceptibility to Thrombosis. American Journal Of Pathology. 182(6). 2082–2093. 7 indexed citations
6.
Johnson, Joshua A., Heidi B. IglayReger, Megan Greenwald-Yarnell, et al.. (2012). Testosterone interacts with the feedback mechanisms engaged by Tyr985 of the leptin receptor and diet-induced obesity. The Journal of Steroid Biochemistry and Molecular Biology. 132(3-5). 212–219. 9 indexed citations
7.
Luo, Wei, Jintao Wang, Chiao Guo, et al.. (2012). Obesity-Induced Endothelial Dysfunction Is Prevented by Deficiency of P-Selectin Glycoprotein Ligand-1. Diabetes. 61(12). 3219–3227. 37 indexed citations
8.
Khan, Sanjoy K., Tadeusz Maliñski, Ronald P. Mason, et al.. (2010). Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model. Thrombosis Research. 126(4). 299–305. 40 indexed citations
9.
Yang, Soo Jin, Heidi B. IglayReger, Hoda C. Kadouh, & Peter F. Bodary. (2009). Inhibition of the chemokine (C–C motif) ligand 2/chemokine (C–C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy. Diabetologia. 52(5). 972–981. 51 indexed citations
10.
Bodary, Peter F., et al.. (2007). Strategies to Reduce Vascular Risk Associated with Obesity. Current Vascular Pharmacology. 5(4). 249–258. 11 indexed citations
11.
Shen, Yuechun, Peter F. Bodary, Jonathon W. Homeister, et al.. (2006). α-Galactosidase A Deficiency Leads to Increased Tissue Fibrin Deposition and Thrombosis in Mice Homozygous for the Factor V Leiden Mutation. Stroke. 37(4). 1106–1108. 20 indexed citations
12.
Eitzman, Daniel T., Randal J. Westrick, Yuechun Shen, et al.. (2005). Homozygosity for Factor V Leiden Leads to Enhanced Thrombosis and Atherosclerosis in Mice. Circulation. 111(14). 1822–1825. 53 indexed citations
13.
Bodary, Peter F., et al.. (2005). Recombinant Leptin Promotes Atherosclerosis and Thrombosis in Apolipoprotein E–Deficient Mice. Arteriosclerosis Thrombosis and Vascular Biology. 25(8). e119–22. 115 indexed citations
14.
Bodary, Peter F., et al.. (2005). IN FOCUS: Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistance. Journal of Thrombosis and Haemostasis. 3(10). 2149–2153. 40 indexed citations
15.
Bodary, Peter F., Yuechun Shen, Randal J. Westrick, et al.. (2004). 1064-182 Gene transfer of an ApoA-I mimetic peptide reduces atherosclerosis in mice. Journal of the American College of Cardiology. 43(5). A465–A466. 3 indexed citations
16.
Brook, Robert D., et al.. (2004). Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults. The American Journal of Cardiology. 93(8). 1012–1016. 76 indexed citations
17.
Rajagopalan, Sanjay, Peter F. Bodary, Damon Duquaine, Bertram Pitt, & Daniel T. Eitzman. (2003). Mineralocorticoid receptor antagonism attenuates thrombotic response to injury in atherosclerosis through favorable effects on nitric oxide bioavailability. Journal of the American College of Cardiology. 41(6). 232–233. 1 indexed citations
18.
Eitzman, Daniel T., et al.. (2003). Fabry Disease in Mice Is Associated With Age-Dependent Susceptibility to Vascular Thrombosis. Journal of the American Society of Nephrology. 14(2). 298–302. 66 indexed citations
19.
Bodary, Peter F.. (2002). Effect of Leptin on Arterial Thrombosis Following Vascular Injury in Mice. JAMA. 287(13). 1706–1706. 192 indexed citations
20.
Bodary, Peter F., et al.. (2002). Recent advances in understanding endogenous fibrinolysis: implications for molecular-based treatment of vascular disorders. Expert Reviews in Molecular Medicine. 4(7). 1–10. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Concetta Di Febbo Breakdown of academic impact, for papers by Michael J. Kraakman Breakdown of academic impact, for papers by Kazuyuki Hida Breakdown of academic impact, for papers by Hiroyuki Mori Breakdown of academic impact, for papers by Josef Wanninger Breakdown of academic impact, for papers by Atsuko Nakatsuka Breakdown of academic impact, for papers by Hirotaka Isobe Breakdown of academic impact, for papers by Nuria Matesanz Breakdown of academic impact, for papers by Jack C.‐R. Tsai Breakdown of academic impact, for papers by Alexander Breitenstein
Rankless by CCL
2026